WWP2调控肾脏纤维化及促纤维化肌成纤维细胞的代谢重编程
研究探讨E3泛素连接酶WWP2在慢性肾脏病(CKD)肾纤维化及肌成纤维细胞代谢重编程中的作用。在CKD患者和小鼠模型中发现WWP2表达升高,WWP2缺失可抑制促纤维化活化、促进肌成纤维细胞增殖并减轻纤维化,机制涉及WWP2-PGC-1α轴调控线粒体呼吸。
要点
- CKD患者及小鼠纤维化肾脏中WWP2表达升高并与纤维化进展相关。
- WWP2缺失可解偶联促纤维化活化与细胞增殖,减轻肾纤维化。
- WWP2通过抑制PGC-1α转录调控肌成纤维细胞代谢重编程。
核心结论
- WWP2通过WWP2-PGC-1α轴调控促纤维化肌成纤维细胞的代谢重编程,WWP2缺失可预防CKD肾纤维化。
研究设计与样本
- 使用CKD患者肾脏样本和WWP2缺失肾脏疾病小鼠模型,并利用单细胞RNA测序分析纤维化肾脏中WWP2的细胞特异性调控。
主要发现
- 在CKD患者和小鼠肾脏疾病模型中,肾小管间质WWP2表达与纤维化进展相关。
- WWP2缺失促进肌成纤维细胞增殖并阻止促纤维化活化,减轻体内肾纤维化严重程度。
- 在肾肌成纤维细胞中,WWP2缺失增加脂肪酸氧化并激活磷酸戊糖途径,增强线粒体呼吸而抑制糖酵解。
- WWP2抑制PGC-1α转录,药理学抑制PGC-1α可部分消除WWP2缺失对肌成纤维细胞的保护作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: WWP2 expression is elevated in the tubulointerstitium of fibrotic kidneys and contributes to CKD pathogenesis and progression. WWP2 uncouples the profibrotic activation and cell proliferation in renal myofibroblasts. WWP2 controls mitochondrial respiration in renal myofibroblasts through the metabolic regulator peroxisome proliferator-activated receptor gamma coactivator 1-alpha. BACKGROUND: Renal fibrosis is a common pathologic end point in CKD that is challenging to reverse, and myofibroblasts are responsible for the accumulation of a fibrillar collagen–rich extracellular matrix. Recent studies have unveiled myofibroblasts' diversity in proliferative and fibrotic characteristics, which are linked to different metabolic states. We previously demonstrated the regulation of extracellular matrix genes and tissue fibrosis by WWP2, a multifunctional E3 ubiquitin–protein ligase. Here, we investigate WWP2 in renal fibrosis and in the metabolic reprograming of myofibroblasts in CKD. METHODS: We used kidney samples from patients with CKD and WWP2-null kidney disease mice models and leveraged single-cell RNA sequencing analysis to detail the cell-specific regulation of WWP2 in fibrotic kidneys. Experiments in primary cultured myofibroblasts by bulk-RNA sequencing, chromatin immunoprecipitation sequencing, metabolomics, and cellular metabolism assays were used to study the metabolic regulation of WWP2 and its downstream signaling. RESULTS: The tubulointerstitial expression of WWP2 was associated with fibrotic progression in patients with CKD and in murine kidney disease models. WWP2 deficiency promoted myofibroblast proliferation and halted profibrotic activation, reducing the severity of renal fibrosis in vivo. In renal myofibroblasts, WWP2 deficiency increased fatty acid oxidation and activated the pentose phosphate pathway, boosting mitochondrial respiration at the expense of glycolysis. WWP2 suppressed the transcription of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a metabolic mediator of fibrotic response, and pharmacologic inhibition of PGC-1α partially abrogated the protective effects of WWP2 deficiency on myofibroblasts. CONCLUSIONS: WWP2 regulates the metabolic reprogramming of profibrotic myofibroblasts by a WWP2-PGC-1α axis, and WWP2 deficiency protects against renal fibrosis in CKD.
引用
- Chen H, You R, Guo J, et al. WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts. J Am Soc Nephrol. 2024. PMID: 38502123. doi:10.1681/ASN.0000000000000328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。